Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Roumier

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Blood|February 21, 2009
C/EBPA methylation is common in T-ALL but not in M0 AMLLouis Terriou, Raouf Ben Abdelali, Christophe Roumier, et al.
Lancet (London, England)|September 29, 2004
Alpha-synuclein locus duplication as a cause of familial Parkinson's diseaseMarie-Christine Chartier-Harlin, Jennifer Kachergus, Christophe Roumier, et al.
Leukemia & Lymphoma|January 9, 2019
Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in <i>KMT2A</i>-rearranged acute lymphoblastic leukemia: a case report and review of the literatureElise Fournier, Luca Inchiappa, Carole Delattre, et al.
Leukemia Research|August 7, 2021
Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometryAdriana Plesa, Christophe Roumier, Joris Gutrin, et al.
The Lancet. Haematology|April 12, 2016
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 studyCéline Berthon, Emmanuel Raffoux, Xavier Thomas, et al.
Leukemia|July 14, 2020
A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosisJonathan Bond, Aleksandra Krzywon, Ludovic Lhermitte, et al.
Blood|October 6, 2016
LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosisAdam Ceroi, David Masson, Anne Roggy, et al.
Blood|March 28, 2013
MYD88 L265P mutation in Waldenstrom macroglobulinemiaStéphanie Poulain, Christophe Roumier, Audrey Decambron, et al.
Annals of Hematology|February 16, 2026
Contribution of a specific panel by flow cytometry for the differential diagnosis of plasmacytoid dendritic cell neoplasmsFlorian Renosi, Sabeha Biichlé, Xavier Roussel, et al.
British Journal of Haematology|August 28, 2014
MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndromeStéphanie Poulain, Eileen M Boyle, Christophe Roumier, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Blood|February 21, 2009
C/EBPA methylation is common in T-ALL but not in M0 AMLLouis Terriou, Raouf Ben Abdelali, Christophe Roumier, et al.
Lancet (London, England)|September 29, 2004
Alpha-synuclein locus duplication as a cause of familial Parkinson's diseaseMarie-Christine Chartier-Harlin, Jennifer Kachergus, Christophe Roumier, et al.
Leukemia & Lymphoma|January 9, 2019
Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in <i>KMT2A</i>-rearranged acute lymphoblastic leukemia: a case report and review of the literatureElise Fournier, Luca Inchiappa, Carole Delattre, et al.
Leukemia Research|August 7, 2021
Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometryAdriana Plesa, Christophe Roumier, Joris Gutrin, et al.
The Lancet. Haematology|April 12, 2016
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 studyCéline Berthon, Emmanuel Raffoux, Xavier Thomas, et al.
Leukemia|July 14, 2020
A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosisJonathan Bond, Aleksandra Krzywon, Ludovic Lhermitte, et al.
Blood|October 6, 2016
LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosisAdam Ceroi, David Masson, Anne Roggy, et al.
Blood|March 28, 2013
MYD88 L265P mutation in Waldenstrom macroglobulinemiaStéphanie Poulain, Christophe Roumier, Audrey Decambron, et al.
Annals of Hematology|February 16, 2026
Contribution of a specific panel by flow cytometry for the differential diagnosis of plasmacytoid dendritic cell neoplasmsFlorian Renosi, Sabeha Biichlé, Xavier Roussel, et al.
British Journal of Haematology|August 28, 2014
MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndromeStéphanie Poulain, Eileen M Boyle, Christophe Roumier, et al.
Pageof 6